Modern approaches in the first line treatment of CD30-positive peripheral T-cell lymphomas
Relevance. Peripheral T-cell lymphomas (PTCL) comprise a heterogeneous group of aggressive lymphoproliferative malignancies that account for approximately 10% of adult non-Hodgkins lymphomas. Despite the variety of PTCL subtypes, CHOP-like regimens are the standard first-line therapy in most cases....
Guardado en:
Autores principales: | Irina V. Poddubnaya, Elena A. Bariakh, Sergei V. Voloshin, Liliia G. Gorenkova, Kamil D. Kaplanov, Alla M. Kovrigina, Nataliia B. Mikhailova, Tatiana I. Pospelova, Vadim V. Ptushkin, Gaiane S. Tumian, Natalia A. Falaleeva, Gulnara N. Khusainova |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
IP Habib O.N.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fe0771127994485f9b77da21b6852fed |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
New opportunities of systemic therapy of CD30-positive primary cutaneous T-cell lymphomas
por: Irina V. Poddubnaya, et al.
Publicado: (2020) -
Modern possibilities of therapy for primary cutaneous T-cell lymphomas: the first results of the use of brentuximab vedotin in the Russian Federation
por: Liliya G. Gorenkova, et al.
Publicado: (2021) -
The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma
por: Lai C, et al.
Publicado: (2019) -
Hodgkin lymphoma. ASCO, EHA and ASH 2020 news
por: Elena A. Demina
Publicado: (2021) -
Promising Immunotherapeutic Modalities for B-Cell Lymphoproliferative Disorders
por: Jana Mihályová, et al.
Publicado: (2021)